ABOUT INDEXING EDITORIAL BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S SUBSCRIPTIONS AUTHOR'S PAGE
Materiale Plastice
Cite as: Mater. Plast.
https://doi.org/10.37358/Mat.Plast.1964

OSIM Nr. R102356
ISSN Print 0025-5289
ISSN Online 2668-8220
Journal Metrics
* Impact factor 2019: 1.517
* 5-Year IF: 1.179
* CiteScore: 2.4
* H index: 22
Materiale Plastice - Latest Issue

Latest Issue >>>
ARCHIVES
   Volume 57, 2020
   Volume 56, 2019
   Volume 55, 2018
   Volume 54, 2017
   Volume 53, 2016
   Volume 52, 2015
   Volume 51, 2014
   Volume 50, 2013
   Volume 49, 2012
   Volume 48, 2011
   Volume 47, 2010
   Volume 46, 2009
   Volume 45, 2008
   Volume 44, 2007
   Volume 43, 2006
   Volume 42, 2005
   Volume 41, 2004
   Volume 40, 2003
 
<<<< back

Materiale Plastice (Mater. Plast.), Year 2019, Volume 56, Issue 1, 194-187

https://doi.org/10.37358/MP.19.1.5150

Decebal Fodor, Bogdan Andrei Suciu, Ioan Jung, Simona Gurzu, Tamas-Csaba Sipos, Attila Doros, Laszlo Kobori

Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects


Abstract:
Hepatocellurar carcinoma (HCC) is the most frequent primary hepatic tumor, the vast majority of patients have less than a 12 month survival rate. The aim of this study was to evaluate the efficacy of TACE in patients with HCC, based on a case series and literature review. The study included 12 consecutive patients with HCC who underwent surgical treatment (resection, liver transplantation ± resection) at the Department of Transplantation and Surgery, Semmelweis University, Budapest, during 2009-2015. All the patients received at least one TACE session. Patients with BCLC B-stage who benefit from TACE and another alternative therapy (eg, RFA) may be associated with or exhibit tumor stagnation, or tumor necrosis in most cases. In C BCLC stages, desperate cases - the two patients to whom TACE was the last therapeutic attitude, despite the predicted prognosis, TACE assured the prolongation of life and increased life quality. In the majority of patients in this study, stage A BCLC, chemoembolization was a therapeutic attitude that allowed subsequent liver transplantation (when it was not feasible initially due to tumor size) or liver resection in apparently inoperable cases. The arterial chemotherapy is the unanimously accepted indication in patients with stage B, BCLC. The data presented encourages us to opt for TACE with the intention of destaging BCLC and giving an operability character to the hepatic tumors (resection ± hepatic transplantation). In stage C BCLC, TACE can be a last attempt to improve the quality of life and to control tumor progression.


Keywords:
hepatocellular carcinoma; transarterial chemoembolization; liver transplantation; liver resection

Issue: 2019 Volume 56, Issue 1
Pages: 194-187
Publication date: 30/03/2019
https://doi.org/10.37358/MP.19.1.5150
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
Citation Styles
Cite this article as:
FODOR, D., SUCIU, B.A., JUNG, I., GURZU, S., SIPOS, T., DOROS, A., KOBORI, L., Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects, Mater. Plast., 56(1), 2019, 194-187.

Vancouver
Fodor D, Suciu BA, Jung I, Gurzu S, Sipos T, Doros A, Kobori L. Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects. Mater. Plast.[internet]. 2019 Jan;56(1):194-187. Available from: https://doi.org/10.37358/MP.19.1.5150


APA 6th edition
Fodor, D., Suciu, B.A., Jung, I., Gurzu, S., Sipos, T., Doros, A. & Kobori, L. (2019). Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects. Materiale Plastice, 56(1), 194-187. https://doi.org/10.37358/MP.19.1.5150


Harvard
Fodor, D., Suciu, B.A., Jung, I., Gurzu, S., Sipos, T., Doros, A., Kobori, L. (2019). 'Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects', Materiale Plastice, 56(1), pp. 194-187. https://doi.org/10.37358/MP.19.1.5150


IEEE
D. Fodor, B.A. Suciu, I. Jung, S. Gurzu, T. Sipos, A. Doros, L. Kobori, "Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects". Materiale Plastice, vol. 56, no. 1, pp. 194-187, 2019. [online]. https://doi.org/10.37358/MP.19.1.5150


Text
Decebal Fodor, Bogdan Andrei Suciu, Ioan Jung, Simona Gurzu, Tamas-Csaba Sipos, Attila Doros, Laszlo Kobori,
Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects,
Materiale Plastice,
Volume 56, Issue 1,
2019,
Pages 194-187,
ISSN 2668-8220,
https://doi.org/10.37358/MP.19.1.5150.
(https://revmaterialeplastice.ro/Articles.asp?ID=5150)
Keywords: hepatocellular carcinoma; transarterial chemoembolization; liver transplantation; liver resection


RIS
TY - JOUR
T1 - Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects
A1 - Fodor, Decebal
A2 - Suciu, Bogdan Andrei
A3 - Jung, Ioan
A4 - Gurzu, Simona
A5 - Sipos, Tamas-Csaba
A6 - Doros, Attila
A7 - Kobori, Laszlo
JF - Materiale Plastice
JO - Mater. Plast.
PB - Materiale Plastice SRL
SN - 2668-8220
Y1 - 2019
VL - 56
IS - 1
SP - 194
EP - 187
UR - https://doi.org/10.37358/MP.19.1.5150
KW - hepatocellular carcinoma
KW - transarterial chemoembolization
KW - liver transplantation
KW - liver resection
ER -


BibTex
@article{MatPlast2019P194,
author = {Fodor Decebal and Suciu Bogdan Andrei and Jung Ioan and Gurzu Simona and Sipos Tamas-Csaba and Doros Attila and Kobori Laszlo},
title = {Transarterial Chemoembolization (TACE) with Lipiodol® in HCC PatientsTechnical, clinical and imagistic aspects},
journal = {Materiale Plastice},
volume = {56},
number = {1},
pages = {194-187},
year = {2019},
issn = {2668-8220},
doi = {https://doi.org/10.37358/MP.19.1.5150},
url = {https://revmaterialeplastice.ro/Articles.asp?ID=5150}
}
<<<< back
 
  Search Authors
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License